Jiří Špaček
- Co-authors
- Ján LacoDavid CibulaVladimír PaličkaPeter VuylstekeHelen MackayJacqui RowbottomSven MahnerMarie Plante
- Topics
- Ovarian cancer diagnosis and treatment (14 papers)Endometrial and Cervical Cancer Treatments (8 papers)Epigenetics and DNA Methylation (7 papers)
- Partner nations
- CzechiaUnited StatesGermany
In The Last Decade
Jiří Špaček
52 papers receiving 1.1k citations
Hit Papers
Peers
Comparison fields: 5 of 81
- Oncology 526
- Reproductive Medicine 370
- Molecular Biology 359
- Surgery 166
- Epidemiology 151
Countries citing papers authored by Jiří Špaček
This map shows the geographic impact of Jiří Špaček's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiří Špaček with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiří Špaček more than expected).
Fields of papers citing papers by Jiří Špaček
This network shows the impact of papers produced by Jiří Špaček. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiří Špaček. The network helps show where Jiří Špaček may publish in the future.
Co-authorship network of co-authors of Jiří Špaček
This figure shows the co-authorship network connecting the top 25 collaborators of Jiří Špaček. A scholar is included among the top collaborators of Jiří Špaček based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiří Špaček. Jiří Špaček is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 31 | |
| 4 | 1 | |
| 5 | 2 | |
| 6 | 62 | |
| 7 | 4 | |
| 8 | 103 | |
| 9 | 0 | |
| 10 | 0 | |
| 11 | 25 | |
| 12 | [Prognostic significance of Pgp, MRP1, and MRP3 in ovarian cancer patients]. | 5 |
| 13 | [Hypersensitivity reactions to carboplatin and paclitaxel - our five-years experiences]. | 1 |
| 14 | [Drug resistance proteins LRP, Pgp, MRP1, MRP3 and MRP5 in ovarian cancer patients]. | 5 |
| 15 | 10 | |
| 16 | 3 | |
| 17 | 19 | |
| 18 | [Proteins of resistance and drug resistance in ovarian carcinoma patients]. | 6 |
| 19 | [Adnexal torsion in childhood]. | 1 |
| 20 | Systemic mastocytosis. Report of a case. | 3 |
About Jiří Špaček
Jiří Špaček is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Microbiology, having authored 59 papers that have together received 1.1k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (14 papers), Endometrial and Cervical Cancer Treatments (8 papers) and Epigenetics and DNA Methylation (7 papers). The work is most often cited by research in Reproductive Medicine (370 citations), Oncology (526 citations) and Obstetrics and Gynecology (130 citations). Jiří Špaček has collaborated with scholars based in Czechia, United States and Germany. Frequent co-authors include Ján Laco, David Cibula, Vladimír Palička, Peter Vuylsteke, Helen Mackay, Jacqui Rowbottom, Sven Mahner, Marie Plante, Christopher Poole and Michael Friedländer. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and The Lancet Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.